| Target Price | $112.20 |
| Price | $111.56 |
| Potential | 0.57% |
| Number of Estimates | 20 |
| 20 Analysts have issued a price target Paccar 2027 . The average Paccar target price is $112.20. This is 0.57% higher than the current stock price. The highest price target is $139.65 25.18% , the lowest is $92.92 16.71% . | |
| A rating was issued by 27 analysts: 11 Analysts recommend Paccar to buy, 15 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Paccar stock has an average upside potential 2027 of 0.57% . Most analysts recommend the Paccar stock at Hold. |
21 Analysts have issued a sales forecast Paccar 2025 . The average Paccar sales estimate is $28.2b . This is 4.66% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $29.9b 1.18% , the lowest is $25.5b 13.78% .
This results in the following potential growth metrics:
| 2024 | $33.7b | 4.17% |
|---|---|---|
| 2025 | $28.2b | 16.37% |
| 2026 | $28.8b | 2.18% |
| 2027 | $32.2b | 11.88% |
| 2028 | $32.1b | 0.40% |
| 2029 | $35.3b | 10.26% |
| 2030 | $33.0b | 6.54% |
18 Analysts have issued an Paccar EBITDA forecast 2025. The average Paccar EBITDA estimate is $3.8b . This is 20.65% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $4.9b 2.69% , the lowest is $2.9b 40.47% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $6.3b | 10.17% |
|---|---|---|
| 2025 | $3.8b | 39.60% |
| 2026 | $4.5b | 17.10% |
| 2027 | $5.3b | 17.80% |
| 2028 | $3.7b | 30.36% |
| 2029 | $6.6b | 80.10% |
| 2024 | 18.78% | 6.27% |
|---|---|---|
| 2025 | 13.56% | 27.79% |
| 2026 | 15.54% | 14.60% |
| 2027 | 16.36% | 5.28% |
| 2028 | 11.44% | 30.07% |
22 Paccar Analysts have issued a net profit forecast 2025. The average Paccar net profit estimate is $2.6b . This is 3.61% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.3b 24.19% , the lowest is $2.1b 20.62% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $4.2b | 9.54% |
|---|---|---|
| 2025 | $2.6b | 37.68% |
| 2026 | $3.2b | 22.32% |
| 2027 | $3.8b | 19.07% |
| 2028 | $4.0b | 6.64% |
| 2029 | $4.8b | 19.61% |
| 2024 | 12.36% | 5.60% |
|---|---|---|
| 2025 | 9.21% | 25.51% |
| 2026 | 11.03% | 19.76% |
| 2027 | 11.74% | 6.44% |
| 2028 | 12.57% | 7.07% |
| 2029 | 13.63% | 8.43% |
22 Analysts have issued a Paccar forecast for earnings per share. The average Paccar EPS is $4.94 . This is 3.33% lower than earnings per share in the financial year 2024. The highest EPS forecast is $6.36 24.46% , the lowest is $4.07 20.35% .
This results in the following potential growth metrics and future valuations:
| 2024 | $7.90 | 9.82% |
|---|---|---|
| 2025 | $4.94 | 37.47% |
| 2026 | $6.04 | 22.27% |
| 2027 | $7.19 | 19.04% |
| 2028 | $7.67 | 6.68% |
| 2029 | $9.17 | 19.56% |
| Current | 21.83 | 86.85% |
|---|---|---|
| 2025 | 22.59 | 3.47% |
| 2026 | 18.47 | 18.24% |
| 2027 | 15.51 | 16.03% |
| 2028 | 14.54 | 6.25% |
| 2029 | 12.16 | 16.37% |
Based on analysts' sales estimates for 2025, the Paccar stock is valued at an EV/Sales of 2.42 and an P/S ratio of 2.08 .
This results in the following potential growth metrics and future valuations:
| Current | 2.31 | 26.92% |
|---|---|---|
| 2025 | 2.42 | 4.77% |
| 2026 | 2.37 | 2.13% |
| 2027 | 2.12 | 10.62% |
| 2028 | 2.13 | 0.40% |
| 2029 | 1.93 | 9.31% |
| 2030 | 2.06 | 6.99% |
| Current | 1.98 | 26.05% |
|---|---|---|
| 2025 | 2.08 | 4.89% |
| 2026 | 2.04 | 2.13% |
| 2027 | 1.82 | 10.62% |
| 2028 | 1.83 | 0.40% |
| 2029 | 1.66 | 9.31% |
| 2030 | 1.77 | 6.99% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Neutral
➜
Overweight
|
Upgrade | Dec 19 2025 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Dec 11 2025 |
| Wells Fargo |
➜
Equal-Weight
|
Initiated | Nov 14 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Oct 22 2025 |
| Wolfe Research |
Underperform
➜
Peer Perform
|
Upgrade | Oct 22 2025 |
| JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Oct 22 2025 |
| Truist Securities |
Hold
➜
Hold
|
Unchanged | Oct 22 2025 |
| Analyst Rating | Date |
|---|---|
|
Upgrade
JP Morgan:
Neutral
➜
Overweight
|
Dec 19 2025 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Dec 11 2025 |
|
Initiated
Wells Fargo:
➜
Equal-Weight
|
Nov 14 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Oct 22 2025 |
|
Upgrade
Wolfe Research:
Underperform
➜
Peer Perform
|
Oct 22 2025 |
|
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Oct 22 2025 |
|
Unchanged
Truist Securities:
Hold
➜
Hold
|
Oct 22 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


